**Analysis:**

UnitedHealth Group reported strong earnings for 2016, with revenue growth of 18% and earnings per share increasing by 25%. The company also reported robust cash flows and a positive outlook for 2017. However, the stock market may be cautious due to uncertainty around the Affordable Care Act (ACA) and potential regulatory changes. Additionally, the company's guidance for 2017 may be impacted by the ongoing Medicaid contract disputes in Pennsylvania.

**Conclusion:**

Given the strong financial performance and positive outlook, the stock is likely to experience a positive impact in the short term. However, the uncertainty around the ACA and potential regulatory changes may cause some volatility in the stock price. The rating is:

**1**